Allergy Thera. Share News (AGY)

Allergy Thera. Information

Buy AGY Shares
Add AGY to Watchlist
Add AGY to Alert

Share Price Information for Allergy Thera. (AGY)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 2.875

Bid: 2.75

Ask: 3.00

Change: 0.00 (0.00%)

Spread: 0.25 (9.091%)

Open: 2.875

High: 3.00

Low: 2.875

Prev. Close: 2.875

Last checked at -

IN BRIEF: Allergy Therapeutics Secures VLP Technology Platform

Fri, 04th Sep 2020 19:39

Allergy Therapeutics PLC - Sussex-based biotechnology firm - Secures virus-like particle technology platform to increase vaccine pipeline through licensing agreement with Saiba AG and DeepVax GmbH.

The company will use their platform to develop and commercialise vaccine targeting cancer tumours, atopic dermatitis and psorasis. Already Allergy has an agreement to develop a new VLP vaccine immunotherapy treatment for peanut allergy sufferers.

Current stock price: 20.50 pence

Year-to-date change: up 100%

By Dayo Laniyan; dayolaniyan@alliancenews.com

More News

15 Jul 2022 11:58

Allegy Therapeutics trades 'robustly' in tough year

(Sharecast News) - Allergy Therapeutics updated the market on the financial year just ended on Friday, with the phase one 'Peanut PROTECT' trial, incorporating "ground-breaking" VLP technology, proceeding as planned, with site initiation visits imminent.

15 Jul 2022 10:33

Allergy Therapeutics expects lower revenue, warns on higher costs

(Alliance News) - Allergy Therapeutics PLC on Friday said it expects annual revenue to fall and, while sales are set to improve in the year ahead, it flagged higher costs.

26 May 2022 22:00

TRADING UPDATES: DP Eurasia posts strong sales growth on Turkey demand

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

4 Mar 2022 20:53

TRADING UPDATES: IOG to cut Gazprom ties; wholesale changes at Donegal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and Tuesday and not separately reported by Alliance News:

3 Mar 2022 19:32

TRADING UPDATES: Avation loss narrows; Franchise Brands profit rises

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

2 Feb 2022 13:25

TRADING UPDATES: Longboat comes up empty; Intercede wins US contract

26 Jan 2022 12:17

Allergy Therapeutics gets US FDA approval for peanut vaccine trial

13 Jan 2022 20:20

TRADING UPDATES: Mobile Streams wins deal; East Imperial revenue jumps

15 Nov 2021 16:05

UK shareholder meetings calendar - next 7 days

27 Oct 2021 14:37

EXECUTIVE CHANGES: GSK adds scientific heft to board ahead of demerger

25 Oct 2021 10:45

Allergy Therapeutics reports positive results from field study

(Sharecast News) - Biotechnology company Allergy Therapeutics announced positive top-line results from its exploratory field study 'G309' to evaluate the efficacy and safety of its short-course subcutaneous allergen-specific immunotherapy candidate 'Grass MATA MPL'.

25 Oct 2021 09:18

Latest Share Chat

Allergy Thera. Share News (AGY)

Share Price Information for Allergy Thera. (AGY)

IN BRIEF: Allergy Therapeutics Secures VLP Technology Platform

Allegy Therapeutics trades 'robustly' in tough year

Allergy Therapeutics expects lower revenue, warns on higher costs

TRADING UPDATES: DP Eurasia posts strong sales growth on Turkey demand

TRADING UPDATES: IOG to cut Gazprom ties; wholesale changes at Donegal

TRADING UPDATES: Avation loss narrows; Franchise Brands profit rises

TRADING UPDATES: Longboat comes up empty; Intercede wins US contract

Allergy Therapeutics gets US FDA approval for peanut vaccine trial

TRADING UPDATES: Mobile Streams wins deal; East Imperial revenue jumps

UK shareholder meetings calendar - next 7 days

EXECUTIVE CHANGES: GSK adds scientific heft to board ahead of demerger

Allergy Therapeutics reports positive results from field study

Allergy Therapeutics shares jump on positive G309 trial results

EARNINGS UPDATES: Harbour Energy enters black; Fonix profit rises

IN BRIEF: Allergy Therapeutics cheers secondary endpoint results

IN BRIEF: Allergy Therapeutics study confirms peanut vaccine potential

Latest Share Chat

Allergy Thera. Share News (AGY)

Share Price Information for Allergy Thera. (AGY)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Allergy Therapeutics Secures VLP Technology Platform

Login to your account

Quickpicks are a member only feature

Login to your account